AI-generated drug begins clinical trials in human patients
Alex Zhavoronkov, left, founder and CEO of Insilico Medicine, and Feng Ren, co-CEO and chief scientific officer, at the company’s robotics lab in Suzhou, China. Source: Insilico Medicine The first …